Penumbra Company Profile (NYSE:PEN)

About Penumbra (NYSE:PEN)

Penumbra logoPenumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NYSE:PEN
  • CUSIP: N/A
  • Web:
  • Market Cap: $2.75 billion
  • Outstanding Shares: 33,627,000
Average Prices:
  • 50 Day Moving Avg: $84.41
  • 200 Day Moving Avg: $74.38
  • 52 Week Range: $49.83 - $90.00
  • Trailing P/E Ratio: 293.19
  • Foreward P/E Ratio: 511.25
  • P/E Growth: -32.56
Sales & Book Value:
  • Annual Revenue: $278.61 million
  • Price / Sales: 9.87
  • Book Value: $11.11 per share
  • Price / Book: 7.36
  • EBIDTA: ($2,820,000.00)
  • Net Margins: 0.61%
  • Return on Equity: 0.61%
  • Return on Assets: 0.53%
  • Current Ratio: 7.16%
  • Quick Ratio: 5.28%
  • Average Volume: 259,752 shs.
  • Beta: 0.15
  • Short Ratio: 0.78

Frequently Asked Questions for Penumbra (NYSE:PEN)

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra Inc (NYSE:PEN) issued its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.04. The business earned $73.21 million during the quarter, compared to analyst estimates of $71.08 million. Penumbra had a net margin of 0.61% and a return on equity of 0.61%. Penumbra's revenue for the quarter was up 26.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.07 earnings per share. View Penumbra's Earnings History.

Where is Penumbra's stock going? Where will Penumbra's stock price be in 2017?

2 brokers have issued 12 month price objectives for Penumbra's shares. Their forecasts range from $91.00 to $96.00. On average, they anticipate Penumbra's stock price to reach $93.50 in the next year. View Analyst Ratings for Penumbra.

Who are some of Penumbra's key competitors?

Who owns Penumbra stock?

Penumbra's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (15.61%), Vanguard Group Inc. (6.63%), BlackRock Inc. (5.43%), Alliancebernstein L.P. (3.87%), Redmile Group LLC (3.24%) and State Street Corp (1.60%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Daniel Donen Davis, Don W Kassing, James Robert Pray, Lynn Rothman, Robert D Evans and Sridhar Kosaraju. View Institutional Ownership Trends for Penumbra.

Who sold Penumbra stock? Who is selling Penumbra stock?

Penumbra's stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Morgan Stanley, First Trust Advisors LP, JPMorgan Chase & Co., PNC Financial Services Group Inc., Credit Suisse AG, Nicholas Investment Partners LP and Carret Asset Management LLC. Company insiders that have sold Penumbra stock in the last year include Adam Elsesser, Arani Bose, Daniel Donen Davis, Don W Kassing, James Robert Pray, Lynn Rothman, Robert D Evans and Sridhar Kosaraju. View Insider Buying and Selling for Penumbra.

Who bought Penumbra stock? Who is buying Penumbra stock?

Penumbra's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Stephens Investment Management Group LLC, Eagle Asset Management Inc., Vanguard Group Inc., Point72 Asset Management L.P., Champlain Investment Partners LLC and Citadel Advisors LLC. View Insider Buying and Selling for Penumbra.

How do I buy Penumbra stock?

Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Penumbra stock cost?

One share of Penumbra stock can currently be purchased for approximately $81.80.

Analyst Ratings

Consensus Ratings for Penumbra (NYSE:PEN) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $93.50 (14.30% upside)

Analysts' Ratings History for Penumbra (NYSE:PEN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/10/2017BMO Capital MarketsReiterated RatingBuy$96.00HighView Rating Details
3/27/2017Canaccord GenuityReiterated RatingBuy$91.00LowView Rating Details
3/14/2016Wells Fargo & CoReiterated RatingOutperformN/AView Rating Details
10/13/2015Bank of America CorpInitiated CoverageBuy -> Buy$46.00 -> $46.00N/AView Rating Details
10/13/2015JPMorgan Chase & Co.Initiated CoverageOverweight$46.00N/AView Rating Details
(Data available from 5/22/2015 forward)


Earnings History for Penumbra (NYSE:PEN)
Earnings by Quarter for Penumbra (NYSE:PEN)
Earnings History by Quarter for Penumbra (NYSE:PEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.06)($0.10)$71.08 million$73.21 millionViewListenView Earnings Details
2/28/2017Q416($0.09)($0.08)$67.54 million$73.10 millionViewListenView Earnings Details
11/3/2016Q316($0.08)($0.04)$63.25 million$67.20 millionViewN/AView Earnings Details
8/9/2016Q216($0.07)$0.01$58.18 million$65.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Penumbra (NYSE:PEN)
Current Year EPS Consensus Estimate: $-0.13 EPS
Next Year EPS Consensus Estimate: $0.16 EPS


Dividend History for Penumbra (NYSE:PEN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Penumbra (NYSE:PEN)
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 57.64%
Insider Trades by Quarter for Penumbra (NYSE:PEN)
Institutional Ownership by Quarter for Penumbra (NYSE:PEN)
Insider Trades by Quarter for Penumbra (NYSE:PEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/24/2017Robert D EvansEVPSell10,000$85.24$852,400.00View SEC Filing  
2/14/2017Robert D EvansEVPSell5,000$75.00$375,000.00View SEC Filing  
2/13/2017Adam ElsesserCEOSell7,700$72.21$556,017.00View SEC Filing  
2/13/2017James Robert PrayInsiderSell1,700$73.04$124,168.00View SEC Filing  
2/13/2017Sridhar KosarajuCFOSell1,600$72.94$116,704.00View SEC Filing  
2/10/2017James Robert PrayInsiderSell23,900$71.08$1,698,812.00View SEC Filing  
2/10/2017Sridhar KosarajuCFOSell15,500$71.49$1,108,095.00View SEC Filing  
2/9/2017Arani BoseInsiderSell22,300$70.44$1,570,812.00View SEC Filing  
2/9/2017Lynn RothmanEVPSell2,700$70.20$189,540.00View SEC Filing  
2/7/2017James Robert PrayInsiderSell4,099$69.09$283,199.91View SEC Filing  
2/7/2017Robert D EvansEVPSell1$70.00$70.00View SEC Filing  
2/6/2017Arani BoseInsiderSell17,100$70.01$1,197,171.00View SEC Filing  
2/6/2017Lynn RothmanEVPSell2,886$70.41$203,203.26View SEC Filing  
2/6/2017Sridhar KosarajuCFOSell100$70.00$7,000.00View SEC Filing  
2/3/2017James Robert PrayInsiderSell15,600$70.39$1,098,084.00View SEC Filing  
2/3/2017Robert D EvansEVPSell5,000$70.35$351,750.00View SEC Filing  
2/3/2017Sridhar KosarajuCFOSell7,800$70.56$550,368.00View SEC Filing  
2/1/2017Adam ElsesserCEOSell21,400$70.98$1,518,972.00View SEC Filing  
2/1/2017Daniel Donen DavisInsiderSell7,298$71.00$518,158.00View SEC Filing  
2/1/2017Lynn RothmanEVPSell4,414$70.99$313,349.86View SEC Filing  
1/31/2017Adam ElsesserCEOSell9,000$71.26$641,340.00View SEC Filing  
1/31/2017Daniel Donen DavisInsiderSell3,000$71.29$213,870.00View SEC Filing  
1/31/2017Lynn RothmanEVPSell1,800$71.27$128,286.00View SEC Filing  
1/30/2017Adam ElsesserCEOSell8,200$70.72$579,904.00View SEC Filing  
1/30/2017Daniel Donen DavisInsiderSell2,698$70.71$190,775.58View SEC Filing  
1/30/2017Lynn RothmanEVPSell1,700$70.79$120,343.00View SEC Filing  
1/27/2017Arani BoseInsiderSell31,500$74.12$2,334,780.00View SEC Filing  
1/27/2017Lynn RothmanEVPSell7,000$74.24$519,680.00View SEC Filing  
1/26/2017Don W KassingDirectorSell3,000$74.50$223,500.00View SEC Filing  
11/16/2016Sridhar KosarajuCFOSell25,000$65.07$1,626,750.00View SEC Filing  
9/9/2016Adam ElsesserCEOSell57,200$71.07$4,065,204.00View SEC Filing  
9/6/2016Arani BoseInsiderSell61,000$70.72$4,313,920.00View SEC Filing  
9/2/2016Robert D EvansEVPSell3,100$70.10$217,310.00View SEC Filing  
8/31/2016Adam ElsesserCEOSell26,000$71.15$1,849,900.00View SEC Filing  
8/31/2016Robert D EvansEVPSell5,300$71.17$377,201.00View SEC Filing  
8/26/2016Adam ElsesserCEOSell26,800$71.06$1,904,408.00View SEC Filing  
8/26/2016Robert D EvansEVPSell5,300$71.03$376,459.00View SEC Filing  
8/24/2016Adam ElsesserCEOSell29,000$72.95$2,115,550.00View SEC Filing  
8/24/2016Robert D EvansEVPSell6,300$73.00$459,900.00View SEC Filing  
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.00View SEC Filing  
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.00View SEC Filing  
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.00View SEC Filing  
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Penumbra (NYSE:PEN)
Latest Headlines for Penumbra (NYSE:PEN)
DateHeadline logoPenumbra, Inc. – Value Analysis (NYSE:PEN) : May 19, 2017 - May 19 at 7:46 PM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : May 18, 2017 - May 19 at 11:56 AM logoPost Earnings Coverage as Becton, Dickinson and Co.'s Quarterly Revenue Increased 5.2%; EPS Jumped 12.8% - May 16 at 9:54 AM logoEdited Transcript of PEN earnings conference call or presentation 9-May-17 8:30pm GMT - May 11 at 8:47 AM logoPenumbra Inc (PEN) Downgraded by Zacks Investment Research - May 11 at 8:26 AM logoZacks: Brokerages Set $87.67 Target Price for Penumbra Inc (PEN) - May 10 at 8:44 PM logoPenumbra Inc (PEN) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS - May 10 at 4:16 PM logoPenumbra (PEN) Q1 Loss Wider than Expected, View Intact - May 10 at 11:43 AM logoPenumbra Inc (PEN) Given Buy Rating at BMO Capital Markets - May 10 at 7:36 AM logoPenumbra, Inc. Reports First Quarter 2017 Financial Results - May 9 at 6:45 PM logoPenumbra reports 1Q loss - May 9 at 5:44 PM logoPenumbra (PEN) Receives Daily Media Sentiment Score of 0.16 - May 8 at 11:45 PM logoForm 4 Penumbra Inc For: Apr 28 Filed by: Kosaraju Sridhar - May 3 at 7:52 PM logoPenumbra, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference - May 3 at 7:52 PM logoPenumbra (PEN) Earning Somewhat Negative Press Coverage, AlphaOne Reports - May 2 at 9:32 PM logo-$0.06 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter - May 1 at 11:02 AM logoPenumbra (PEN) Receiving Favorable Press Coverage, Report Finds - April 28 at 12:30 AM logoForm 3 Penumbra Inc For: Apr 21 Filed by: O'Rourke Bridget - April 26 at 11:08 PM logoInsider Selling: Penumbra Inc (PEN) EVP Sells 10,000 Shares of Stock - April 26 at 8:22 PM logoPenumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference ... - April 25 at 6:19 PM logoPenumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference Call for May 9, 2017 at 4:30 PM Eastern Time - April 25 at 6:19 PM logoPenumbra (PEN) Earning Very Favorable Press Coverage, Analysis Shows - April 24 at 12:56 PM logoBRIEF-Penumbra appoints Bridget O'Rourke to board of directors - April 21 at 6:59 PM logoPenumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors - April 21 at 6:59 PM logoZacks: Penumbra Inc (PEN) Receives Average Recommendation of "Strong Buy" from Analysts - April 20 at 3:20 PM logoPenumbra (PEN) Given Daily News Impact Score of 0.19 - April 18 at 9:17 PM logoPenumbra (PEN) Receives Daily Media Sentiment Score of 0.31 - April 15 at 2:55 PM logoPenumbra's (PEN) Buy Rating Reiterated at BMO Capital Markets - April 15 at 2:22 PM logoETFs with exposure to Penumbra, Inc. : April 13, 2017 - April 13 at 6:58 PM logoPenumbra Inc (PEN) Expected to Post Quarterly Sales of $71.99 Million - April 9 at 7:34 AM logoZacks: Penumbra Inc (PEN) Receives Consensus Recommendation of "Strong Buy" from Analysts - April 6 at 8:04 AM logoPenumbra's (PEN) Buy Rating Reiterated at Canaccord Genuity - March 27 at 10:16 PM logoPENUMBRA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - March 22 at 7:10 PM logoBRIEF-Penumbra announces pricing of offering of 1.3 mln shares of its common stock - March 17 at 12:56 AM logoPenumbra, Inc. Announces Pricing of Offering of 1,300,000 Shares of its Common Stock - March 17 at 12:56 AM logoPenumbra, Inc. Announces Launch of Offering of 1300000 Shares of its Common Stock - PR Newswire (press release) - March 16 at 8:37 AM logoBRIEF-Penumbra launches offering of 1.3 mln shares of common stock - March 16 at 12:24 AM logoPenumbra, Inc. (PEN) Announces Launch of 1.3M Share Offering - March 16 at 12:24 AM logoPenumbra, Inc. (PEN) Announces Launch of 1.3M Share Offering - - March 15 at 7:21 PM logoPenumbra, Inc. Announces Launch of Offering of 1,300,000 Shares of its Common Stock - March 15 at 7:21 PM logo4:01 pm Penumbra commences an underwritten public offering of 1,300,000 shares of its common stock - March 15 at 7:21 PM logoPENUMBRA INC Financials - March 4 at 7:13 PM logoPenumbra Reaches Analyst Target Price - March 4 at 8:32 AM logoPenumbra Announces Key Events at Society of Interventional Radiology 2017 Meeting - March 2 at 8:45 AM logoBRIEF-Penumbra Q4 loss per share $0.08 - March 1 at 10:15 AM logoEdited Transcript of PEN earnings conference call or presentation 28-Feb-17 10:00pm GMT - March 1 at 10:15 AM logoPenumbra (PEN) Q4 Loss Narrower than Expected, Sales Top - March 1 at 10:15 AM logoPenumbra, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results - February 28 at 7:12 PM logo4:15 pm Penumbra beats by $0.01, beats on revs; guides FY17 revs in-line - February 28 at 7:12 PM logoPENUMBRA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - February 28 at 7:12 PM


Penumbra (PEN) Chart for Monday, May, 22, 2017

This page was last updated on 5/22/2017 by Staff